Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 4966 AL 4980

What is the prevalence of sleep disturbances among people with Huntington disease and pre-manifest genetic expansion carriers? A systematic review and meta-analysis

Sneddon NJ, D'Rozario AL, Teixeira-Pinto A, Loy CT.

Sleep Med Rev. 2026 Apr;86:102258. doi: 10.1016/j.smrv.2026.102258. Epub 2026 Feb 17.

Phosphodiesterase 9 (PDE9) Inhibitors May Provide Effective Treatments for Neurodegenerative, Cardiovascular and Other Diseases

Abdel-Magid AF.

ACS Med Chem Lett. 2026 Apr 8;17(5):999-1001. doi: 10.1021/acsmedchemlett.6c00167. eCollection 2026 May 14.

Cannabinoids, the Blood-Brain Barrier, and Neurodegeneration: Mechanisms, Dysregulation, and Therapeutic Perspectives

Ben-Shabat S, Yarmolinsky L, Sharon N, Zeadnaa-Aldda T, Dayan S, Khalfin B, Fleisher-Berkovich S.

Biomolecules. 2026 Feb 2;16(2):225. doi: 10.3390/biom16020225.

A Systematic Review on Isoquinoline Derivatives as Emerging Multi-target Agents in Alzheimer's and Parkinson's Disorder Therapy

Subramanian I, Surajambika RR, Sekar D, Natarajan R, Nagarajan NC.

Cent Nerv Syst Agents Med Chem. 2026 Mar 19. doi: 10.2174/0118715249401454260108062419. Online ahead of print.

Prolonged Tardive Dyskinesia Induced by Long-Acting Paliperidone Palmitate in Schizophrenia: A Case Report

Chen YM, Chang S.

Am J Case Rep. 2026 Jan 10;27:e949867. doi: 10.12659/AJCR.949867.

Brain Organoids as Emerging Platforms for Modeling Neurodegenerative Diseases: Progress, Challenges, and Future Directions

Kaya Y, Kırboğa KK.

J Neurochem. 2026 Mar;170(3):e70395. doi: 10.1111/jnc.70395.

Marine-Derived bioactive compounds from Aquaculture: Receptor-Mediated neuroprotection in neurodegenerative disorders

Patwekar F, Patwekar M, Wei LS, Rather GA, Mohammed A, Hussain MS, Gupta G, Fuloria S, Fuloria NK.

Brain Res. 2026 May 15;1879:150208. doi: 10.1016/j.brainres.2026.150208. Epub 2026 Feb 14.

Epigenetic Dysregulation in Neurodegeneration: The Role of Histone Deacetylases and Emerging Inhibitor Strategies

Pawar Y, Kopranovic A, C S R, Meyer-Almes FJ.

Biomolecules. 2026 Jan 7;16(1):103. doi: 10.3390/biom16010103.

From protector to perpetrator: The cGAS-STING pathway at the intersection of neurodegeneration and neuroinflammation

Oriquat G, Abdulqader AF, Farid H, Ashurov Z, Sottarov A, Ghafl NY, Bainsal N, Singh R.

Brain Res Bull. 2026 May 25;241:111963. doi: 10.1016/j.brainresbull.2026.111963. Online ahead of print.

Tailoring treatments: pharmacogenomics in the management of neurodegenerative diseases

Roy KK, Kumari R, Upadhyay AK, Mohanty S.

Acta Neurol Belg. 2026 Feb 10. doi: 10.1007/s13760-025-02919-4. Online ahead of print.

Mitochondrial Dysfunction in the Inflammatory Process of Neurodegenerative Diseases

Nesci S.

Biomedicines. 2026 Mar 16;14(3):682. doi: 10.3390/biomedicines14030682.

Clozapine-Induced Myocarditis in Huntington's Disease: Case Report

Turhan NÖ.

Turk Psikiyatri Derg. 2026;37:49-53. doi: 10.5080/u27742.

The role of neurogenesis in neurodegenerative diseases: Mechanisms and interventions

Chen R, Qiu Z, Luo Y, Fu Y, Cui X, Jiang M.

Ageing Res Rev. 2026 May 5;119:103160. doi: 10.1016/j.arr.2026.103160. Online ahead of print.

Targeting non-apoptotic regulated cell death (RCD) to treat neurodegenerative diseases

Zhao W, Lai Y, Li Z, Yuan Z, Wen Z, Zhang L.

Acta Pharm Sin B. 2026 May;16(5):2601-2644. doi: 10.1016/j.apsb.2026.01.040. Epub 2026 Feb 2.

Current knowledge of Huntington's disease-like 2 genetic testing, clinical presentation, and patient experiences: A systematic review

Hoffmann K, White S, Sexton A.

J Huntingtons Dis. 2026 Jan 21:18796397251411109. doi: 10.1177/18796397251411109. Online ahead of print.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias